EL II: P38 MAP Kinase Inhibitors as Therapeutics Targeting Ebolavirus Entry

Project: Other project

StatusFinished
Effective start/end date8/1/126/30/14

Funding

  • Icahn School of Medicine at Mount Sinai: $82,945.02